Xiaoquan Huang | Health and Medicine Advances | Research Excellence Award

Published on by New Scientists

Dr. Xiaoquan Huang | Health and Medicine Advances | Research Excellence Award

Associate Researcher | Zhongshan Hospital, Fudan University | China

Dr. Xiaoquan Huang is an accomplished clinical researcher whose work centers on gastroenterology, hepatology, metabolic liver disease, portal hypertension, gastrointestinal bleeding, and global disease epidemiology. With 848 Scopus citations, 79 publications, and an h-index of 13, his research demonstrates sustained impact across Health Sciences, Pharmacology & Toxicology, Cardiology, Endocrinology, Geriatrics, Neurology, Psychiatry, Pulmonary Medicine, Radiology, and related clinical domains. His research portfolio features high-quality journal publications in Chinese Medical Journal, Journal of Gastroenterology and Hepatology, Thrombosis and Haemostasis, Endoscopy, Liver International, Therapeutic Advances in Chronic Disease, and Journal of Translational Medicine. His works span clinical investigations, systematic reviews, global burden analyses, and translational studies addressing cirrhosis-related complications, portal vein thrombosis, metabolic-associated fatty liver disease, and early-onset colorectal cancer. Dr. Xiaoquan Huang has also served as a corresponding author on several influential global epidemiology studies focused on colorectal cancer and fatty liver disease burden.  Dr. Xiaoquan Huang’s scholarly contributions include research on variceal bleeding management, endoscopic innovations, thrombosis prediction markers, myeloproliferative neoplasm-associated portal hypertension, and gastrointestinal microbiome trends. His findings have advanced evidence-based approaches for cirrhotic complications, individualized treatment strategies, endoscopic therapy optimization, and risk stratification in liver disease. He has contributed to meta-analyses and systematic reviews, including work on transoral incisionless fundoplication (TIF) for GERD and therapeutic evaluations in portal hypertension, expanding global clinical understanding and practice guidelines. His research awards include multiple Young Investigator accolades from APDW, EASL, and JGHF, reflecting international recognition for innovation and research excellence. Dr. Xiaoquan Huang’s academic leadership includes reviewer service, conference presentations, and contributions to collaborative global research projects. His ongoing work continues to shape diagnostic, therapeutic, and epidemiological frameworks in hepatology and gastroenterology, establishing him as a significant contributor to clinical research and patient-centered innovations.

Profiles: Scopus | ORCID | ResearchGate | Sci Profiles

Featured Publications

1. Huang, X., Zou, D., Wang, H., Chen, W., Zhang, L., Li, F., Ma, L., Zhang, C., Chen, Y., & Chen, S. (2024). Gastric variceal obstruction improves the efficacy of endoscopic management of esophageal variceal bleeding in GOV type I. Endoscopy International Open, 12(8), E940–E946.

2. Wang, Y., Huang, X. (Corresponding author), Cheryala, M., Aloysius, M., Zheng, B., Yang, K., Chen, B., Fang, Q., Chowdary, S. B., Abougergi, M. S., & Chen, S. (2023). Global increase of colorectal cancer in young adults over the last 30 years: An analysis of the Global Burden of Disease Study 2019. Journal of Gastroenterology and Hepatology, 38(9), 1552–1558.

3. Jiang, S., Ai, Y., Fan, X., Huang, X. (Corresponding author), Wu, L., Ni, L., Li, F., & Chen, S. (2023). Increased factor VIII activity is predictive of the occurrence of portal vein thrombosis in cirrhosis. Thrombosis and Haemostasis, 123(7), 714–722.

4. Huang, X., Zhang, M., Ai, Y., Jiang, S., Xiao, M., Wang, L., Jian, Y., Zhuge, Y., Zhang, C., & Chen, S. (2022). Characteristics of myeloproliferative neoplasm-associated portal hypertension and endoscopic management of variceal bleeding. Therapeutic Advances in Chronic Disease, 13, Article 20406223221125691.

5. Huang, X., Abougergi, M. S., Sun, C., Murphy, D., Sondhi, V., Chen, B., Zheng, X., Chen, S., & Wang, Y. (2023). Incidence and outcomes of thromboembolic and bleeding events in patients with liver cirrhosis in the USA. Liver International, 43(2), 434–441.

Bing Han | Health and Medicine Advances | Best Researcher Award

Published on by New Scientists

Dr. Bing Han | Health and Medicine Advances | Best Researcher Award

Postdoctoral Researcher, The First Affiliated Hospital of Zhengzhou University, China

Dr. Bing Han, Professor at The First Affiliated Hospital of Zhengzhou University, China, is an accomplished medical scientist and clinician whose research bridges molecular biology, microbiome science and clinical gastroenterology. He earned his medical degree (M.D.) followed by postdoctoral research training focused on digestive disease mechanisms and microbial interactions, establishing a strong foundation in translational and precision medicine. His primary research interests center on the gut microbiota–host interaction, bile acid metabolism, intestinal inflammation and biomarker discovery for digestive disorders, with emerging interests in microbiome-based therapeutic interventions. Over his distinguished career, Dr. Bing Han has held academic and clinical roles at The First Affiliated Hospital of Zhengzhou University and collaborated with The First Affiliated Hospital of the University of Science and Technology of China, contributing to interdisciplinary advancements in medical research. His key scientific contributions include innovative studies on the mechanisms of fecal microbiota transplantation in improving inflammatory bowel disease (IBD) and the development of biomedical devices such as spinal positioning systems and femoral defect fixation stents. He has published 9 scientific documents, receiving 50 citations with an h-index of 5 and authored the academic book Frontiers of Tumor Research. Among his notable research supports are the China Postdoctoral Science Foundation Grant, National Natural Science Foundation of China Grant and the Guangxi Natural Science Foundation and Health Commission Projects of Guangxi Zhuang Autonomous Region. His professional engagements include serving as a Young Editorial Board Member for the Journal of Guangxi Medical University and membership in the Digestive Professional Committee of the Chinese Society of Pathophysiology and the Gut Microbiota Branch of the Chinese Society of Biophysics. Through his pioneering research on gut microbiota and digestive pathophysiology, Dr. Bing Han aims to revolutionize clinical diagnostics and therapeutics, promoting global health advancement and innovation in biomedical science.

Profile: Scopus | ORCID | ResearchGate

Featured Publications

1. Han, B., Tang, D., Zhu, H., et al. (2024). Integrated multi-omics reveal gut microbiota-mediated bile acid metabolism regulating immunotherapy responses to anti-α4β7-integrin in Crohn’s disease. Gut Microbes, 16(1), 2310894.

2. Han, B., Li, C., Meng, H., et al. (2019). Efficacy and safety of external-beam radiation therapy for hepatocellular carcinoma: An overview of current evidence according to the different target population. Bioscience Trends, 13(1), 10–22.

3. Han, B., Tang, D., Lv, X., et al. (2023). Comparative efficacy and safety of combination therapy with infliximab for Crohn’s disease: A systematic review and network meta-analysis. International Journal of Colorectal Disease, 38(1), 82.

4. Han, B., Shao, L., Li, C., et al. (2019). Surgery versus external beam radiation therapy for AJCC stage I hepatocellular carcinoma. Journal of BUON, 24(4), 1390–1401.

5. Han, B., Yao, H., Shao, L., et al. (2018). Selection of treatment modalities for hepatocellular carcinoma at stages T1 and T2: A preliminary analysis based on the Surveillance, Epidemiology, and End Results registry database. Journal of BUON, 23(3), 611–621.